No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells

This study reports findings from a 56-year-old patient, who had received bilateral intravitreal injection of putative adipose tissue-derived stem cells at a private clinic in India with the promise of treatment of NAION. During an observation period of 8, respectively, 18 months, the intravitreally...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in ophthalmological medicine 2019, Vol.2019 (2019), p.1-3
Main Authors: Faber, Carsten, Kiilgaard, Jens Folke, Heegaard, Steffen
Format: Article
Language:English
Subjects:
Adipose tissues
Body fat
Case Report
Case reports
Eyes & eyesight
Injections
Macular degeneration
Patient safety
Patients
Retina
Side effects
Stem cells
Transplantation
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study reports findings from a 56-year-old patient, who had received bilateral intravitreal injection of putative adipose tissue-derived stem cells at a private clinic in India with the promise of treatment of NAION. During an observation period of 8, respectively, 18 months, the intravitreally injected cells remained silent in the vitreous bodies without either therapeutic effects or complications. The cells cleared with vitrectomy without evidence of integration in the optic nerve or retina. Contrary to recent reports on patients receiving intravitreal injections of similar putative stem cells with the aim of treating AMD, our patient suffered no devastating ocular consequences. Summary. Contrary to recent reports, this case demonstrated no devastating consequences of intravitreal injection of adipose tissue-derived stem cells during an observation period of up to 18 months. After vitrectomy, the cells cleared without evidence of either harm or integration.
ISSN:2090-6722
2090-6730
DOI:10.1155/2019/6927829